Division of Nutritional Sciences, Cornell University, Ithaca, NY, USA; National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Am J Clin Nutr. 2023 May;117(5):985-997. doi: 10.1016/j.ajcnut.2023.01.016. Epub 2023 Apr 19.
RBC folate concentrations are monitored at the population level, with a recommended threshold for optimal neural tube defect (NTD) prevention. A corresponding threshold for serum folate has not been established.
This study aimed to estimate the serum folate insufficiency threshold corresponding to the RBC folate threshold for NTD prevention and examine how this threshold is modified by vitamin B status.
Participants were women (15-40 y; not pregnant or lactating; n = 977) from a population-based biomarker survey in Southern India. RBC folate and serum folate were measured via microbiologic assay. RBC folate deficiency (<305 nmol/L) and insufficiency (<748 nmol/L), serum vitamin B deficiency (<148 pmol/L) and vitamin B insufficiency (<221 pmol/L), elevated plasma MMA (>0.26 μmol/L), elevated plasma homocysteine (>10.0 μmol/L), and elevated HbA1c (≥6.5%) were evaluated. Bayesian linear models were used to estimate unadjusted and adjusted thresholds.
Compared with adequate vitamin B status, the estimated serum folate threshold was higher in participants with serum vitamin B deficiency (72.5 vs. 28.1 nmol/L) or vitamin B insufficiency (48.7 vs. 24.3 nmol/L) and elevated MMA (55.6 vs. 25.9 nmol/L). The threshold was lower in participants with elevated HbA1c (HbA1c ≥6.5% vs. <6.5%; 21.0 vs. 40.5 nmol/L).
The estimated serum folate threshold for optimal NTD prevention was similar to previous reports (24.3 vs. 25.6 nmol/L) among participants with sufficient vitamin B status. However, this threshold was more than 2-fold higher in participants with vitamin B deficiency and substantially higher across all indicators of insufficient vitamin B status (<221 pmol/L, elevated MMA, combined B, impaired vitamin B status), and lower in participants with elevated HbA1c. Findings suggest a serum folate threshold for NTD prevention may be possible in some settings; however, it may not be appropriate in populations with high prevalence of vitamin B insufficiency. Am J Clin Nutr 2023;xx:xx-xx. This trial was registered at https://clinicaltrials.gov as NCT04048330.
红细胞叶酸浓度在人群水平上进行监测,存在推荐的最佳神经管缺陷(NTD)预防阈值。尚未确定血清叶酸的相应阈值。
本研究旨在估计与 NTD 预防的红细胞叶酸阈值相对应的血清叶酸不足阈值,并研究该阈值如何受维生素 B 状态的影响。
参与者为来自印度南部一项基于人群的生物标志物调查的女性(15-40 岁;非妊娠或哺乳期;n=977)。通过微生物测定法测量红细胞叶酸和血清叶酸。评估红细胞叶酸缺乏症(<305 nmol/L)和不足症(<748 nmol/L)、血清维生素 B 缺乏症(<148 pmol/L)和维生素 B 不足症(<221 pmol/L)、升高的血浆 MMA(>0.26 μmol/L)、升高的血浆同型半胱氨酸(>10.0 μmol/L)和升高的 HbA1c(≥6.5%)。使用贝叶斯线性模型来估计未调整和调整后的阈值。
与维生素 B 状态充足的参与者相比,血清维生素 B 缺乏症(72.5 比 28.1 nmol/L)或维生素 B 不足症(48.7 比 24.3 nmol/L)和升高的 MMA(55.6 比 25.9 nmol/L)的参与者血清叶酸的估计阈值更高。HbA1c 升高(HbA1c≥6.5%比<6.5%;21.0 比 40.5 nmol/L)的参与者血清叶酸阈值更低。
在具有足够维生素 B 状态的参与者中,最佳 NTD 预防的血清叶酸阈值与之前的报告相似(24.3 比 25.6 nmol/L)。然而,在维生素 B 缺乏症的参与者中,该阈值高出两倍多,并且在所有维生素 B 不足的指标中(<221 pmol/L、升高的 MMA、综合维生素 B、维生素 B 状态受损)都显著更高,而在 HbA1c 升高的参与者中则更低。研究结果表明,在某些情况下,可能存在用于预防 NTD 的血清叶酸阈值,但在维生素 B 不足症患病率较高的人群中可能并不适用。Am J Clin Nutr 2023;xx:xx-xx。本试验在 https://clinicaltrials.gov 上注册为 NCT04048330。